Webinar
on demand
30
Jan
2023
17
00
CET
Interstitial Lung Disease (ILD): a rare but severe side-effect

This session is part of the SPCC Adverse Events Management and Interstitial Lung Disease (ILD) Detection Project. Following the Task Force - held in 2022 - the fourth phase of the project will focus on the results emerged from the discussion on the new strategies to tackle adverse events on Interstitial Lung Disease Cancer.

 

 

Speakers
Discussant
Rugo Hope

Winterhof Family Professor of Breast Cancer Director, Breast Oncology and Clinical Trials Education Medical Director, Cancer Infusion Services, San Francisco, USA
Expert
Addeo Alfredo

Oncology Division, University Hospital Geneva, Geneve, Switzerland
Expert
Bergeron Anne

Pneumology Dept., Hôpitaux Universitaires Genève, Geneva, Switzerland
Expert
Senan Suresh

Amsterdam University Medical Centers, VUmc location, Amsterdam, The Netherlands
This material is part of Educational Project:
2022 - Adverse Events Management and Interstitial Lung Disease (ILD) Detection Project